Showing results (201-210 of 214) with videos related to
Sort By:
Pageof 22
European Urology Focus|May 5, 2020
Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer RegistryJessica C L Notohardjo, Malou C P Kuppen, Hans M Westgeest, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
Unfolded Von Willebrand Factor Binds Protein S and Reduces Anticoagulant ActivityMartha M S Sim, Molly Y Mollica, Hammodah R Alfar, et al.Blood Vessels, Thrombosis & Hemostasis|June 16, 2025
Unfolded von Willebrand factor binds protein S and reduces anticoagulant activityMartha M S Sim, Molly Y Mollica, Hammodah R Alfar, et al.Clinical Genitourinary Cancer|December 30, 2019
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the NetherlandsMalou C P Kuppen, Hans M Westgeest, Alphonsus J M van den Eertwegh, et al.Annals of the Rheumatic Diseases|October 10, 2009
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in CaucasiansB Rueda, P Gourh, J Broen, et al.Clinical Genitourinary Cancer|August 24, 2019
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the NetherlandsHans M Westgeest, Malou C P Kuppen, Alphonsus J M van den Eertwegh, et al.Journal of Palliative Medicine|August 20, 2021
High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients: Results from the Dutch CAPRI-RegistryHans M Westgeest, Malou C P Kuppen, Fons A J M van den Eertwegh, et al.European Urology Oncology|October 12, 2019
Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer RegistryMalou C P Kuppen, Hans M Westgeest, Alphonsus J M van den Eertwegh, et al.European Urology Focus|July 30, 2017
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer RegistryHans M Westgeest, Carin A Uyl-de Groot, Reindert J A van Moorselaar, et al.Blood|January 24, 2016
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myelomaSonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, et al.Pageof 22